| Literature DB >> 28284345 |
Sindhu Jacob1, Asmaa Al-Kandari2, Raed Alroughani3, Rabeah Al-Temaimi4.
Abstract
In a cross-sectional study involving 160 Multiple Sclerosis (MS) patients and 70 healthy controls we set out to determine the association of five blood biomarkers with MS risk and progression scores. High levels of Semaphorin3A (SEMA3A) in females, and low levels of prolactin and estradiol in males associated with MS risk. High MS disability correlated with higher SEMA3A levels in females. Our findings suggest the clinical applicability of SEMA3A, and prolactin as biomarkers for MS progression. However, these biomarkers had sex-specific associations with MS, and any therapeutic approaches utilizing them should take that into consideration.Entities:
Keywords: Multiple Sclerosis; Prolactin; Semaphorin3A; Sphingomyelin; Testosterone
Mesh：
Substances：
Year: 2017 PMID： 28284345 DOI： 10.1016/j.jneuroim.2017.01.008
Source DB: PubMed Journal: J Neuroimmunol ISSN： 0165-5728 Impact factor: 3.478